Barclays PLC Merck & Co., Inc. Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$111.15 - $128.97 $16.6 Million - $19.3 Million	-149,600 Reduced 96.89%	4,800 $545,000
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $10.1 Million - $10.8 Million	81,500 Added 111.8%	154,400 $19.1 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $7.89 Million - $9.2 Million	-69,700 Reduced 48.88%	72,900 $9.62 Million
Q4 2023 Feb 15, 2024	BUY	$100.18 - $109.02 $14.3 Million - $15.5 Million	142,600 New	142,600 $15.5 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $813,226 - $907,394	7,900 Added 2.48%	325,900 $34.7 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $23 Million - $29.4 Million	262,600 Added 474.01%	318,000 $35.3 Million
Q3 2022 Nov 03, 2022	BUY	$84.53 - $94.96 $3.55 Million - $3.99 Million	42,000 Added 313.43%	55,400 $4.77 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $37.7 Million - $42.8 Million	-452,100 Reduced 97.12%	13,400 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $29.5 Million - $37 Million	408,200 Added 712.39%	465,500 $35.7 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $3.94 Million - $4.34 Million	55,000 Added 2391.3%	57,300 $4.3 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $5.99 Million - $6.63 Million	-85,200 Reduced 97.37%	2,300 $179,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $18.6 Million - $21.9 Million	-269,700 Reduced 75.5%	87,500 $6.75 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $7.35 Million - $8.16 Million	102,400 Added 40.19%	357,200 $29.2 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $13.9 Million - $15.8 Million	-190,000 Reduced 42.72%	254,800 $21.1 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $11.3 Million - $12.8 Million	-160,100 Reduced 26.47%	444,800 $34.4 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $13.5 Million - $18.7 Million	213,000 Added 54.35%	604,900 $46.5 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $24.8 Million - $28 Million	-319,400 Reduced 44.9%	391,900 $35.6 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $5.23 Million - $5.7 Million	68,700 Added 10.69%	711,300 $59.9 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $10.4 Million - $12.2 Million	-149,500 Reduced 18.87%	642,600 $53.9 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $9.99 Million - $11.4 Million	-143,600 Reduced 15.35%	792,100 $65.9 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $11.9 Million - $13.8 Million	181,800 Added 24.11%	935,700 $71.5 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $17.5 Million - $20.6 Million	304,100 Added 67.61%	753,900 $53.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $9.48 Million - $11.1 Million	-186,600 Reduced 29.32%	449,800 $27.3 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $7.47 Million - $8.68 Million	146,500 Added 29.9%	636,400 $34.7 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $14.7 Million - $17.5 Million	284,600 Added 138.63%	489,900 $27.6 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $12 Million - $13 Million	205,300	205,300 $13.1 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.7 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.9 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.59 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.92 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account